Equity Incentive Plans (Tables)

3 Months Ended

Mar. 31, 2025

Equity Incentive Plans

Schedule of Stock Option Activity

				Weighted
				Average
		Weighted		Remaining
		Average		Contractual	Aggregate
		Exercise		Term	Intrinsic
	Shares	Price		(Years)	Value (in thousands)
Outstanding at December 31, 2024	3,755,965	$	3.74	7.5	$	4
Granted	1,596,058	$	2.04		$	—
Exercised	—	$	—		$	—
Forfeited/Cancelled/Expired	(75,500)	$	4.86		$	—
Outstanding at March 31, 2025	5,276,523	$	3.21	8.1	$	—
Vested and expected to vest at March 31, 2025	5,276,523	$	3.21	8.1	$	—
Exercisable at March 31, 2025	2,411,689	$	3.91	6.6	$	—

Schedule of Restricted Stock Awards and Restricted Stock Unit Activity

		Weighted Avg
		Grant Date
	Shares	Fair Value
Outstanding at December 31, 2024	220,000	$	2.73
Granted	—	$	—
Vested	(17,500)	$	3.38
Cancelled	—	$	—
Outstanding at March 31, 2025	202,500	$	2.65

Schedule of Assumptions Used in the Black-Scholes Model

	Three Months Ended March 31,
	2025	2024
Risk-free interest rate	4.27%-4.30%	4.24%-4.25%
Expected volatility	99.64%-101.43%	89.40%-92.5%
Expected term (in years)	5.75-6.25	5.12-7.0
Expected dividend yield	0%	0%

Schedule of Stock-Based Compensation Expenses

The table below summarizes the total share-based compensation expense included in the Company’s condensed consolidated statements of operations for the periods presented (in thousands):

	Three Months Ended March 31,
	2025		2024
Research and development	$	320	$	52
General and administrative		461		482
Total stock-based compensation	$	781	$	534